CPT® Code 0815T

Ultrasound-based radiofrequency echographic multi-spectrometry (REMS), bone-density study and fracture-risk assessment, 1 or more sites, hips, pelvis, or spine

An ultrasound-based radiofrequency echographic multi-spectrometry (REMS) bone-density study is a non-invasive diagnostic procedure designed to evaluate bone health and assess the risk of fractures. This advanced technology utilizes ultrasound waves rather than ionizing radiation to analyze the bone structure, making it a safer alternative for patients. The primary objective of the REMS study is to identify the presence of osteoporosis, a condition characterized by weakened bones that are more susceptible to fractures. By examining specific skeletal sites, such as the hips, pelvis, or spine, the procedure aims to predict the likelihood of fragility fractures, which can significantly impact a patient's quality of life. During the study, the patient is positioned supine, and a convex ultrasound probe is placed over the targeted area. The transducer is carefully adjusted to focus on the appropriate depth for optimal evaluation of the bone structure. The echographic scan captures raw ultrasound signals, which are then processed by specialized software to identify areas of interest. The analysis of these signals allows for the estimation of bone mineral density, categorizing the bone as healthy, osteoporotic, or osteopenic. Following the procedure, a comprehensive report is generated, detailing the patient's bone status. This report is subsequently reviewed and interpreted by a physician, who compares the findings with established models of bone density and fracture risk, taking into account factors such as age, gender, site, and body mass index (BMI). The results of the REMS study are crucial in guiding clinical decisions regarding the initiation of hormone replacement therapy or preventive treatments for osteoporosis.